Back to Search
Start Over
Cephamycin resistance in clinical isolates and laboratory-derived strains of Escherichia coli, Nova Scotia, Canada.
- Source :
-
Emerging infectious diseases [Emerg Infect Dis] 2003 Oct; Vol. 9 (10), pp. 1254-9. - Publication Year :
- 2003
- Subjects :
- Anti-Bacterial Agents pharmacology
Base Sequence
Cefoxitin pharmacology
DNA, Bacterial genetics
Drug Resistance, Multiple, Bacterial genetics
Escherichia coli genetics
Escherichia coli Infections drug therapy
Escherichia coli Infections microbiology
Escherichia coli Proteins genetics
Genes, Bacterial
Humans
In Vitro Techniques
Molecular Sequence Data
Mutation
Nova Scotia
Porins genetics
Promoter Regions, Genetic
beta-Lactam Resistance genetics
Cephamycins pharmacology
Escherichia coli drug effects
Escherichia coli isolation & purification
Subjects
Details
- Language :
- English
- ISSN :
- 1080-6040
- Volume :
- 9
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Emerging infectious diseases
- Publication Type :
- Academic Journal
- Accession number :
- 14609460
- Full Text :
- https://doi.org/10.3201/eid0910.030093